ProKidney
PROK
69 hedge funds and large institutions have $42M invested in ProKidney in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 10 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 18
2.74% less ownership
Funds ownership: 39.79% → 37.05% (-2.7%)
7% less funds holding
Funds holding: 74 → 69 (-5)
33% less call options, than puts
Call options by funds: $4K | Put options by funds: $6K
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
51% less capital invested
Capital invested by funds: $86.1M → $42M (-$44M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
+$383K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$297K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$125K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$121K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$91.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.05M |
| 2 |
Goldman Sachs
New York
|
-$103K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88.7K |
| 4 |
Barclays
London,
United Kingdom
|
-$73.2K |
| 5 |
Mariner
Overland Park,
Kansas
|
-$64.4K |
PROK Hedge Fund Activity: Q1 2025 in Review
69 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2025, worth a combined $42M — down 51% from $86.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of PROK and 5 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 30 added.
The largest buyer was Hennion & Walsh Asset Management, adding an estimated $383K. The largest seller was Morgan Stanley, cutting an estimated $5.05M.
- 69 institutional investors held ProKidney (PROK) as of Q1 2025, down from 74 in Q4 2024.
- Funds reported $42M of ProKidney stock for Q1 2025, down 51% quarter-over-quarter.
- 5 funds opened new ProKidney positions in Q1 2025 and 10 closed out, a net change of -5 holders.
- The largest ProKidney buyer in Q1 2025 was Hennion & Walsh Asset Management, an estimated $383K added.
- The largest ProKidney seller in Q1 2025 was Morgan Stanley, an estimated $5.05M sold.
Based on aggregated 13F filings for Q1 2025.